Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has shared an announcement.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. and Sunshine Lake Pharma Co., Ltd. have announced a monthly update on their proposed pre-conditional privatization merger. The merger is progressing, with the NDRC approval obtained and the MoC approval deemed unnecessary. However, approvals from SAFE and the Stock Exchange are still pending, leaving some pre-conditions unfulfilled. The merger’s completion is contingent upon these approvals and other conditions, impacting the company’s future operations and market positioning.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company incorporated in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the development and production of various pharmaceutical products, with a market focus on China.
Average Trading Volume: 5,435,028
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.35B
For detailed information about 1558 stock, go to TipRanks’ Stock Analysis page.